LOCUS       NP_001003377             401 aa                     MAM 23-FEB-2014
DEFINITION  beta-3 adrenergic receptor [Canis lupus familiaris].
ACCESSION   NP_001003377
VERSION     NP_001003377.1  GI:50979252
KEYWORDS    RefSeq.
SOURCE      Canis lupus familiaris (dog)
  ORGANISM  Canis lupus familiaris
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Laurasiatheria; Carnivora; Caniformia; Canidae;
            Canis.
REFERENCE   1  (residues 1 to 401)
  AUTHORS   Masutani S, Cheng HJ, Morimoto A, Hasegawa H, Han QH, Little WC and
            Cheng CP.
  TITLE     beta3-Adrenergic receptor antagonist improves exercise performance
            in pacing-induced heart failure
  JOURNAL   Am. J. Physiol. Heart Circ. Physiol. 305 (6), H923-H930 (2013)
   PUBMED   23873794
  REMARK    GeneRIF: In conclusion, after HF, beta3-ANT improves LV diastolic
            filling; increases LV contractility, LV arterial coupling, and
            mechanical efficiency; and improves exercise performance.
REFERENCE   2  (residues 1 to 401)
  AUTHORS   Sheng L, Shen Q, Huang K, Liu G, Zhao J, Xu W, Liu Y, Li W and Li Y.
  TITLE     Upregulation of beta3-adrenergic receptors contributes to atrial
            structural remodeling in rapid pacing induced atrial fibrillation
            canines
  JOURNAL   Cell. Physiol. Biochem. 30 (2), 372-381 (2012)
   PUBMED   22739404
  REMARK    GeneRIF: The Adrenergic beta-3 Receptor was upregulated in paced
            atria, which contributed to oxidative stress and exacerbated atrial
            structural remodeling by regulating p38 MAPK.
REFERENCE   3  (residues 1 to 401)
  AUTHORS   Lenzen G, Pietri-Rouxel F, Drumare MF, Amiard A, Guillot S,
            Archimbault P and Strosberg AD.
  TITLE     Genomic cloning and species-specific properties of the recombinant
            canine beta3-adrenoceptor
  JOURNAL   Eur. J. Pharmacol. 363 (2-3), 217-227 (1998)
   PUBMED   9881593
REFERENCE   4  (residues 1 to 401)
  AUTHORS   Candelore MR, Deng L, Tota LM, Kelly LJ, Cascieri MA and Strader CD.
  TITLE     Pharmacological characterization of a recently described human beta
            3-adrenergic receptor mutant
  JOURNAL   Endocrinology 137 (6), 2638-2641 (1996)
   PUBMED   8641219
COMMENT     PROVISIONAL REFSEQ: This record has not yet been subject to final
            NCBI review. The reference sequence was derived from AF200597.1.
            ##Evidence-Data-START##
            Transcript exon combination :: AF200597.1 [ECO:0000332]
            ##Evidence-Data-END##
FEATURES             Location/Qualifiers
     source          1..401
                     /db_xref="taxon:9615"
                     /sub_species="familiaris"
                     /organism="Canis lupus familiaris"
                     /chromosome="16"
                     /map="16"
     Protein         1..401
                     /function="responsible for the lipolytic effects of
                     endogenous catecholamines on adipocytes"
                     /note="beta 3 adrenergic receptor; beta-3 adrenoceptor;
                     beta-3 adrenoreceptor; adrenergic, beta-3-, receptor"
                     /product="beta-3 adrenergic receptor"
                     /calculated_mol_wt="42474"
     Site            37..63
                     /note="propagated from UniProtKB/Swiss-Prot (O02662.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          54..>145
                     /note="Serpentine type 7TM GPCR chemoreceptor Srsx;
                     pfam10320"
                     /db_xref="CDD:255903"
                     /region_name="7TM_GPCR_Srsx"
     Region          60..346
                     /note="7 transmembrane receptor (rhodopsin family);
                     pfam00001"
                     /db_xref="CDD:249497"
                     /region_name="7tm_1"
     Site            73..91
                     /note="propagated from UniProtKB/Swiss-Prot (O02662.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            112..133
                     /note="propagated from UniProtKB/Swiss-Prot (O02662.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            156..178
                     /note="propagated from UniProtKB/Swiss-Prot (O02662.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          198..212
                     /note="propagated from UniProtKB/Swiss-Prot (O02662.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="Agonist and antagonist binding (By
                     similarity)"
     Site            204..225
                     /note="propagated from UniProtKB/Swiss-Prot (O02662.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            293..314
                     /note="propagated from UniProtKB/Swiss-Prot (O02662.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          305..312
                     /note="propagated from UniProtKB/Swiss-Prot (O02662.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="Agonist and antagonist binding (By
                     similarity)"
     Site            327..347
                     /note="propagated from UniProtKB/Swiss-Prot (O02662.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          332..336
                     /note="propagated from UniProtKB/Swiss-Prot (O02662.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="Agonist and antagonist binding (By
                     similarity)"
     CDS             1..401
                     /coded_by="NM_001003377.1:1..1206"
                     /gene="ADRB3"
                     /gene_synonym="B3AR; GPCR"
                     /db_xref="GeneID:442979"
ORIGIN
        1 mapwphgngs vaswpaaptp tpdaantsgl pgapwavala gallalevla tvggnllviv
       61 aiartprlqt mtnvfvtsla tadlvvgllv vppgatlalt grwplgatgc elwtsvdvlc
      121 vtasietlca lavdrylavt nplrygalvt krraraavvl vwvvsaavsf apimskwwrv
      181 gadaeaqrch snphccafas nipyallsss vsfylpllvm lfvyarvflv atrqlrllrr
      241 elgrfppaes ppaasrsrsp gparrcaspa avpsdrlrpa rllplrehra lrtlglivgt
      301 ftlcwlpffv anvmralggp slvpspalla lnwlgyansa fnpliycrsp dfrsafrrll
      361 crcrreehra aasppgdpsa apaaltspae ssrcpaldgv s
//
